These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6219819)

  • 21. [Chloasma during treatments with synthetic estroprogestagens].
    Thiers H; Villedieu P; Moulin G
    G Ital Dermatol Minerva Dermatol; 1966; 107(5):1335-8. PubMed ID: 6014651
    [No Abstract]   [Full Text] [Related]  

  • 22. [Estrogen and progesterone cytosol receptor concentrations in patients with endometriosis and their changes after gossypol therapy].
    Zhang YW; Han ML; Wang YF
    Zhonghua Fu Chan Ke Za Zhi; 1994 Apr; 29(4):220-3, 253. PubMed ID: 8082445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecule of the month: asoprisnil.
    Drug News Perspect; 2005; 18(6):404. PubMed ID: 16247518
    [No Abstract]   [Full Text] [Related]  

  • 24. Progesterone reduces neurofilament (NF)--positive nerve fibers in eutopic endometrium of patients with endometriosis and myomata.
    Kim YA; Kim JY; Chang SH; Chang DY; Chun KC; Koh JW
    J Reprod Med; 2014; 59(9-10):481-7. PubMed ID: 25330691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist.
    Ichigo S; Takagi H; Matsunami K; Suzuki N; Imai A
    Arch Gynecol Obstet; 2011 Sep; 284(3):667-70. PubMed ID: 21052701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum CA 125 concentrations in women with endometriosis or uterine fibroids treated with gonadotrophin-releasing hormone agonist analogues.
    van der Spuy ZM; Wood M; Fieggen G; Hendricks MS
    S Afr Med J; 1993 Jul; 83(7):510-3. PubMed ID: 8211493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Structural and functional characteristics of the endometrium in uterine myoma at the early stages in detection of the tumor and during norsteroid treatment].
    Iakubovich DV; Kondrikov NI
    Akush Ginekol (Mosk); 1980 Jan; (1):41-2. PubMed ID: 7377477
    [No Abstract]   [Full Text] [Related]  

  • 28. [Advanced endometriosis treatment with leuprolide acetate].
    Valdés P; Sierralta P
    Rev Chil Obstet Ginecol; 1993; 58(5):405-10. PubMed ID: 7991863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical application of mifepristone in obstetrics and gynecology].
    Weng L
    Zhonghua Fu Chan Ke Za Zhi; 1999 May; 34(5):261-4. PubMed ID: 11326928
    [No Abstract]   [Full Text] [Related]  

  • 30. Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis.
    Chwalisz K; Perez MC; Demanno D; Winkel C; Schubert G; Elger W
    Endocr Rev; 2005 May; 26(3):423-38. PubMed ID: 15857972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen and progestin cytosol receptor concentrations in patients with endometriosis and their changes after gossypol therapy.
    Zhang Y; Wang Y; Li C; Zhou J; Zhang D; Han M
    Chin Med J (Engl); 1996 Oct; 109(10):814-6. PubMed ID: 9275362
    [No Abstract]   [Full Text] [Related]  

  • 32. [Gonadotropin-releasing hormone analogs].
    Krysiak R; Okopień B; Herman ZS
    Pol Merkur Lekarski; 2005 May; 18(107):585-9. PubMed ID: 16161962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gonadotropic and steroid hormone excretion during 17-oxyprogesterone caproate therapy of primary endometrial cancer].
    Mezinova NN; Bogdanova AG; Khan OG
    Akush Ginekol (Mosk); 1973 Jan; 49(1):40-4. PubMed ID: 4695993
    [No Abstract]   [Full Text] [Related]  

  • 34. The use of gonadotrophin-releasing hormone analogues in gynaecology.
    Lo KW; Lau TK
    Chin Med J (Engl); 1997 Oct; 110(10):746-9. PubMed ID: 9642302
    [No Abstract]   [Full Text] [Related]  

  • 35. [Combination of uterine adenomyosis with leiomyoma].
    Anichkov NM; Pechenikova VA
    Arkh Patol; 2005; 67(3):31-4. PubMed ID: 16075610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Conservative treatment and prevention of uterine myoma].
    Starovoĭtov IM; Gerasimovich GI; Lukashevich GA
    Akush Ginekol (Mosk); 1972 Apr; 48(4):17-20. PubMed ID: 4344756
    [No Abstract]   [Full Text] [Related]  

  • 37. [Adjuvant therapy in uterine myoma].
    Vikhliaeva EM
    Vestn Ross Akad Med Nauk; 1997; (2):16-20. PubMed ID: 9376721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gynecological indications of a new progestational agent with prolonged action].
    Goisis M; Candotti G
    Minerva Ginecol; 1970 Mar; 22(6):339-67. PubMed ID: 5515153
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomas.
    Maruo T; Ohara N; Matsuo H; Xu Q; Chen W; Sitruk-Ware R; Johansson ED
    Contraception; 2007 Jun; 75(6 Suppl):S99-103. PubMed ID: 17531625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical applications of GnRH agonists in gynaecology.
    Preutthipan S
    J Med Assoc Thai; 1993 Jan; 76 Suppl 1():11-8. PubMed ID: 8113648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.